Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on August 14, 2018. The filing reports the Company's financial performance for the second fiscal quarter ended June 30, 2018. Note: The input metadata references "Clearpoint Neuro, Inc.," but the filing text explicitly identifies the registrant as "MRI Interventions, Inc."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms the issuance of a press release regarding the Q2 2018 results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. It serves solely as a notification of the press release (Exhibit 99.1) and includes a standard disclaimer that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name (MRI Interventions, Inc. vs. Clearpoint Neuro, Inc.) in the context of your investment thesis.
- Locate and review Exhibit 99.1 (Press Release dated August 14, 2018) to obtain actual financial figures for the quarter ended June 30, 2018.
- Confirm whether the press release contains updated guidance or material risk factors not detailed in this 8-K summary.